Pancreatic injury in COVID-19: pathogenesis and challenges

Rev Esp Enferm Dig. 2020 Nov;112(11):891. doi: 10.17235/reed.2020.7541/2020.

Abstract

Apart from the mechanisms reported by Fernandes et al, the thromboembolic pathogenesis should also be taken into account in patients with severe COVID-19 and prophylaxis with low molecular weight heparin should be implemented.

Publication types

  • Letter

MeSH terms

  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 / physiopathology
  • Humans
  • Pancreatic Diseases / diagnosis
  • Pancreatic Diseases / physiopathology
  • Pancreatic Diseases / virology*
  • Thromboembolism / diagnosis
  • Thromboembolism / physiopathology
  • Thromboembolism / virology*